Sequenom's Q3 Revenues Jump 51 Percent on MassArray Sales, CRS Business | GenomeWeb
NEW YORK (GenomeWeb News) - Sequenom late yesterday said third-quarter revenue surged 51 percent as R&D spending declined 6.6 percent and net loss widened 20 percent.
Total receipts for the three months ended Sept. 30 rose to $9.8 million from $6.5 million year over year.
CEO Harry Stylli said in a statement that the increase was driven by “strong contributions from MassArray system placements and consumables as well as our Contract Research Services business.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.